Last reviewed · How we verify
Combined diphtheria, tetanus, acellular pertussis vaccine
Combined diphtheria, tetanus, acellular pertussis vaccine is a Biologic drug developed by GlaxoSmithKline. It is currently FDA-approved.
At a glance
| Generic name | Combined diphtheria, tetanus, acellular pertussis vaccine |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PHASE4)
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) (PHASE1)
- Safety Monitoring of Boostagen® Vaccine in Thailand
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine (PHASE1, PHASE2)
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (PHASE3)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children (PHASE4)
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combined diphtheria, tetanus, acellular pertussis vaccine CI brief — competitive landscape report
- Combined diphtheria, tetanus, acellular pertussis vaccine updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Combined diphtheria, tetanus, acellular pertussis vaccine
What is Combined diphtheria, tetanus, acellular pertussis vaccine?
Combined diphtheria, tetanus, acellular pertussis vaccine is a Biologic drug developed by GlaxoSmithKline.
Who makes Combined diphtheria, tetanus, acellular pertussis vaccine?
Combined diphtheria, tetanus, acellular pertussis vaccine is developed and marketed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
What development phase is Combined diphtheria, tetanus, acellular pertussis vaccine in?
Combined diphtheria, tetanus, acellular pertussis vaccine is FDA-approved (marketed).